Back to search results

A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

Abroad (travel likely)RecruitingPHASE2

Conditions

Treatment Resistant Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Noble Clinical Research, Tucson, Arizona, United States

  • Pillar Clinical Research, LLC, Little Rock, Arkansas, United States

  • Preferred Research Partners, Inc., Little Rock, Arkansas, United States

  • Woodland Research Northwest, Rogers, Arkansas, United States

  • CenExel, Garden Grove, California, United States

  • Behavioral Research Specialists, LLC, Glendale, California, United States

  • Kadima Neuropsychiatry Institute, La Jolla, California, United States

  • Collaborative Neuroscience Research, LLC, Los Alamitos, California, United States

  • TRIP Clinical at Psychedelic Science Institute, Santa Monica, California, United States

  • Mountain View Clinical Research Inc., Denver, Colorado, United States

  • CenExel, Hollywood, Florida, United States

  • Bioresearch Partner, Miami, Florida, United States

  • University of South Florida, Psychiatry and Behavioral Neurosciences, Tampa, Florida, United States

  • CenExcel, Decatur, Georgia, United States

  • CenExel, Savannah, Georgia, United States

  • Pillar Clinical Research LLC, Chicago, Illinois, United States

  • Sheppard Pratt, Baltimore, Maryland, United States

  • Sunstone Medical, PC, Rockville, Maryland, United States

  • Elixia MA, Springfield, Massachusetts, United States

  • Adams Clinical, Watertown, Massachusetts, United States

  • Institute for Integrative Therapies, Eden Prairie, Minnesota, United States

  • Midwest Research Group, Saint Charles, Missouri, United States

  • Clinilabs, LLC, Eatontown, New Jersey, United States

  • Bio Behavioral Health, Toms River, New Jersey, United States

  • The Medical Research Network, LLC, New York, New York, United States

  • The Ohio State University, Columbus, Ohio, United States

  • Neuro Behavioral Clinical Research, Inc., North Canton, Ohio, United States

  • Scranton Medical Institute, LLC, Moosic, Pennsylvania, United States

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • Biobehavioral Research of Austin, Austin, Texas, United States

  • InSite Clinical Research, DeSoto, Texas, United States

  • Aim Trials, LLC, Plano, Texas, United States

  • Cedar Clinical Research Inc, Draper, Utah, United States

  • Seattle Neuropsychiatric Treatment Center, Bellevue, Washington, United States

  • Sydney Local Health District (SLHD) Mental Health, Camperdown, New South Wales, Australia

  • Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

  • NeuroCentrix, Carlton, Victoria, Australia

  • The University of Melbourne, Carlton, Victoria, Australia

  • Royal Melbourne Hospital, Melbourne, Victoria, Australia

  • Paratus Clinical Research Melbourne, Northcote, Victoria, Australia

  • Royal Melbourne Hospital Parkville, Parkville, Victoria, Australia

  • University of Melbourne, Parkville, Victoria, Australia

  • Centre for Neurology Studies, Surrey, British Columbia, Canada

  • Providence Care Hospital, Kingston, Ontario, Canada

  • Clerkenwell Health, Doncaster, England, United Kingdom

  • Clerkenwell Health, London, England, United Kingdom

  • NeuroClin, Motherwell, England, United Kingdom

  • Clerkenwell Health, London, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)